PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Ophthalmology10.3341/kjo.2015.29.3.1602015293160The Association between Choroidal Thickness Variations and Response to Intravitreal Bevacizumab in Central Serous ChorioretinopathyDong Yoon Kim, Soo Geun Joe, Sung Jae Yang, Joo Yong Lee, June-Gone Kim, Young Hee Yoonhttps://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2015.29.3.160, https://synapse.koreamed.org/pdf/10.3341/kjo.2015.29.3.160, http://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2015.29.3.160
10.21203/rs.2.15383/v12019Prognostic factor for the response to intravitreal bevacizumab treatment in central serous chorioretinopathy patients.Chunghyun Lee, Yu Jeong Kim, Soo Geun Joe, Sungjae Yanghttps://www.researchsquare.com/article/rs-6049/v1, https://www.researchsquare.com/article/rs-6049/v1.html
Japanese Journal of Ophthalmology10.1007/s10384-012-0138-32012563245-249Intravitreal bevacizumab for iatrogenic choroidal neovascularization due to laser photocoagulation in central serous chorioretinopathyYoko Nomura, Ryo Obata, Yasuo Yanagihttp://link.springer.com/content/pdf/10.1007/s10384-012-0138-3.pdf, http://link.springer.com/article/10.1007/s10384-012-0138-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10384-012-0138-3
European Journal of Ophthalmology10.5301/ejo.50000362011223488-491Intravitreal bevacizumab for choroidal neovascularization secondary to laser photocoagulation for central serous chorioretinopathyJoseph Pikkel, Shimon Rumelthttp://journals.sagepub.com/doi/pdf/10.5301/ejo.5000036, http://journals.sagepub.com/doi/full-xml/10.5301/ejo.5000036, http://journals.sagepub.com/doi/pdf/10.5301/ejo.5000036
Acta Ophthalmologica Scandinavica10.1111/j.1600-0420.2007.01062_3402.x2007850-0Photodynamic therapy with Verteporfin combined with intravitreal injection of Bevacizumab for central serous chorioretinopathyM MAIERhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0420.2007.01062_3402.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0420.2007.01062_3402.x/fullpdf
Acta Ophthalmologica10.1111/j.1755-3768.2016.0249201694The long-term effect of intravitreal bevacizumab injection in central serous chorioretinopathyS.J. Mun, C. Choi, J.G. Jeonghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2016.0249, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2016.0249/fullpdf
Journal of the Korean Ophthalmological Society10.3341/jkos.2012.53.9.135220125391352Intravitreal Bevacizumab Injection for Choroidal Neovascularization Secondary to Laser Photocoagulation for Central Serous ChorioretinopathyJong Hyun Jung, Kun Moon, Kwang Soo Kim, Yu Cheol Kimhttps://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2012.53.9.1352, https://synapse.koreamed.org/pdf/10.3341/jkos.2012.53.9.1352, http://synapse.koreamed.org/DOIx.php?id=10.3341/jkos.2012.53.9.1352
Optometry - Journal of the American Optometric Association10.1016/j.optm.2010.04.0912010818383-384The effectiveness of intravitreal injection of bevacizumab for management of central serous chorioretinopathyMarc D. Myershttps://api.elsevier.com/content/article/PII:S1529183910002551?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1529183910002551?httpAccept=text/plain
Acta Ophthalmologica10.1111/j.1755-3768.2013.f053.x2013910-0Effect of intravitreal bevacizumab for chronic, recurrent, or atypical central serous chorioretinopathyJH SONG, YR CHUNG, MH KIM, HM LEWhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2013.F053.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2013.F053.x/fullpdf
Choroidal Disorders10.1016/b978-0-12-805313-3.00009-02017139-159Central Serous ChorioretinopathyMarta Zola, Sobha Sivaprasadhttps://api.elsevier.com/content/article/PII:B9780128053133000090?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128053133000090?httpAccept=text/plain